David Weill, Director at TransMedics Group, Inc. (TMDX), bought 2,500 shares at $62.00 ($155K) on 2023-08-29, disclosed to the SEC on 2023-08-30.
Open-market purchase of $155k TMDX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| TMDX | SELL | 2025-12-05 | $1.4M | — | Filing → |
| TMDX | SELL | 2025-05-23 | $181K | — | Filing → |
| TMDX | SELL | 2024-05-31 | $338K | — | Filing → |